Parametric Portfolio Associates’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Parametric Portfolio Associates’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,926	Closed	-$98K	–	3897
2016 Q3	$98K	Buy	+10,926	New	+$77.7K	﹤0.01%	3684
2014 Q3	–	Sell	-18,656	Closed	-$215K	–	3953
2014 Q2	$215K	Buy	+18,656	New	+$170K	﹤0.01%	3696

Parametric Portfolio Associates's RPTP Position: Q4 2016 in Review

Parametric Portfolio Associates sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 10,926 shares — an estimated $98K sold.

Parametric Portfolio Associates first reported a position in RPTP in Q2 2014 and held it in 2 quarters. The position peaked at $215K in Q2 2014. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Parametric Portfolio Associates reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Parametric Portfolio Associates sold 10,926 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $98K.
Parametric Portfolio Associates first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2014 and held it in 2 quarters.
Parametric Portfolio Associates's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $215K in Q2 2014.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Parametric Portfolio Associates's 13F filing for Q4 2016, filed 14 Feb 2017.